Careverse Technology Ltd

Careverse Technology is a global technology company that boldly ventures into the frontier where “artificial intelligence + healthcare” intersect. It stands as a global leader in advancing the fusion of artificial intelligence with medical imaging. Over the past six years, Careverse Technology has consistently pushed the boundaries of industry technology. They have steadfastly adhered to offering the healthcare sector comprehensive, intelligent and innovative smart health solutions driven by original Chinese creativity and global leadership in artificial intelligence technology. Careverse Technology’s AI products for coronary arteries, head and neck, and liver are all groundbreaking innovations in the field of artificial intelligence. As of October 2023, Careverse Technology has obtained FDA certification from the United States for two of its artificial intelligence products, namely, head and neck CTA and CTP. Additionally, four of their AI products, including coronary artery CTA, head and neck CTA, lung nodules, and pneumonia, have received MDR CE certification from the European Union. The company has also accumulated a total of 9 Chinese NMPA Class III certificates, 13 NMPA Class III certificates, 2 FDA certifications from the United States, and 4 MDR CE certifications from the European Union. It was founded in 2017.